- OCuSOFT relaunches Tears Again advanced Liposome Spray
- Pfizer forms licensing agreement with Seattle Genetics
- New cardiovascular risk calculator now available online
- Walgreens puts its money where its mouth is with World AIDS Day campaign
- Walgreens launches high-impact push in support of World AIDS Day campaign
INDIANAPOLIS — A drug made by Eli Lilly & Co. produced "significant" improvements in patients with erectile dysfunction who also had benign prostatic hyperplasia, according to results of a new study.
The phase-3 study, published in the Journal of Sexual Medicine, found that Cialis (tadalafil) improved erectile dysfunction and benign prostatic hyperplasia in men with both conditions. BPH is a condition in which the prostate enlarges, causing urinary symptoms.
The Food and Drug Administration approved Cialis to treat both conditions on Thursday.